Biosimilars – a Different type of aHUS Drug
Biosimilar drugs are having an increased presence in conversations about the aHUS therapeutic drug landscape. Here's why they're of interest.
Biosimilar drugs are having an increased presence in conversations about the aHUS therapeutic drug landscape. Here's why they're of interest.
USTMA has partnered with Machaon Diagnostics to offer free ADAMTS13 testing through the new ‘Fast 4 TMA’ program for patients in…
In crime programmes when someone lands on the ground from a great height the question asked is “were they pushed or…
Temos o prazer de oferecer mais uma em nossa série de “SHUa ao redor do mundo”, onde apresentamos as notícias e…
We’re pleased to announce the theme of ‘Capabilities & Possibilities’ as a focus to mark the 9th annual aHUS Awareness Day…
Currently the aHUS patient website belonging to the atypical HUS Foundation, www.aHUS.org is “ under construction” ,or being reconstructed, so it…
It hard to believe that three years have passed since COVID consumed our lives. Although it was a respiratory disease from…
Health care and better estimating lead us to believe there are approaching 3000 aHUS patients in the USA who have survived…
Diagnosing aHUS patients without kidney involvement has always seemed paradoxical. TMA can affect capillaries in all organs but the “u” in…